Questions/Treatment Planning/Q2 of 43
intermediatetreatment-resistant depressionaugmentationaripiprazoleSTAR*DTRD
A 52-year-old man with major depressive disorder has failed two adequate trials of SSRIs (escitalopram 20 mg for 8 weeks and sertraline 200 mg for 10 weeks) with minimal improvement. His PHQ-9 remains at 20. He has no psychotic features, no substance use disorder, and is medically stable. His psychiatrist is considering augmentation strategies.
← PreviousAll Treatment PlanningNext →